HIGHLIGHTS
- What: The authors report a case of a delayed response months after the cessation of immunotherapy in a patient who initially had progressive malignant pleural mesothelioma with metastases. This study has also shown that cisplatin and pemetrexed chemotherapy provides a median overall survival of 12 months and a median progression free survival of 5.7 months .
- Who: Otaq208 from the Royal Perth Hospital, Perth, WA, Australia Curtin Medical School, Curtin University, WA, Australia have published the paper: Trends in Immunotherapy 8(2), in the Journal: (JOURNAL)
- How: The results showed that the 3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.